Predictors of Intracranial Hemorrhage in ARDS Patients on ECMO

Last updated: October 26, 2019
Sponsor: Charite University, Berlin, Germany
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hemorrhage

Acute Respiratory Distress Syndrome (Ards)

Treatment

N/A

Clinical Study ID

NCT04142775
ChariteMM
  • Ages > 18
  • All Genders

Study Summary

Intracranial hemorrhage is is a rare, but critical incident in patients with acute lung failure undergoing ECMO therapy. Predictors of intracranial hemorrhage are yet to be defined to identify patients at (high) risk. This retrospective analysis investigates the predictive value and validity of parameters and specific risk factors of critically ill ARDS patients treated with ECMO.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • ARDS following Berlin definition (mild, moderate, severe)

  • ECMO therapy (veno-venous cannulation)

Exclusion

Exclusion Criteria:

  • ECMO, other than VV

  • ICH at initiation of ECMO

  • no cerebral CT scan at any time

Study Design

Total Participants: 1000
Study Start date:
February 01, 2019
Estimated Completion Date:
March 31, 2020

Connect with a study center

  • Charite university medicine Berlin

    Berlin,
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.